Ultragenyx Pharmaceutical

RARE

Valor de mercado US$ 1,65 bi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
301	301 Truvestments Capital Sarasota, Florida	US$ 768	–	–	–
302	IAIM 302 International Assets Investment Management Orlando, Florida	US$ 712	–	–	–
303	303 CVA Family Office Denver, Colorado	US$ 701	+US$ 522	+21	Nova
304	304 Bare Financial Services Gap, Pennsylvania	US$ 668	+US$ 497	+20	Nova
305	305 MV Capital Management Bethesda, Maryland	US$ 635	+US$ 25	+1	+6%
306	306 Parkside Financial Bank & Trust Saint Louis, Missouri	US$ 435	-US$ 869	-35	-73%
307	307 WPG Advisers Baltimore, Maryland	US$ 367	–	–	–
308	308 Godfrey Financial Associates Glenmont, New York	US$ 267	–	–	–
309	CH 309 Cromwell Holdings Jackson, Wyoming	US$ 234	–	–	–
310	310 Activest Wealth Management Aventure, Florida	US$ 33	–	–	–
311	311 Hughes Financial Services Herndon, Virginia	US$ 33	–	–	–
312	JHC 312 Jones Hill Capital New York	–	-US$ 24,4 mi	-1.165.557	Encerrada
313	313 Point72 Asset Management Stamford, Connecticut	–	-US$ 18,7 mi	-893.295	Encerrada
314	314 HRT Financial New York	–	-US$ 15,2 mi	-613.229	Encerrada
315	NM 315 Newtyn Management New York	–	-US$ 8,38 mi	-400.000	Encerrada
316	316 Balyasny Asset Management Chicago, Illinois	–	-US$ 8,05 mi	-384.364	Encerrada
317	317 Parkman Healthcare Partners Stamford, Connecticut	–	-US$ 4,92 mi	-235.000	Encerrada
318	318 Motley Fool Wealth Management Alexandria, Virginia	–	-US$ 4,67 mi	-222.981	Encerrada
319	319 Jane Street New York	–	-US$ 4,32 mi	-173.743	Encerrada
320	320 Natixis Paris, France	–	-US$ 1,71 mi	-81.754	Encerrada
321	NICM 321 Neo Ivy Capital Management New York	–	-US$ 1,54 mi	-73.601	Encerrada
322	322 Birchview Capital Burlington, Vermont	–	-US$ 1,3 mi	-62.000	Encerrada
323	323 Nordea Investment Management Stockholm, Sweden	–	-US$ 1,2 mi	-57.939	Encerrada
324	324 Tudor Investment Corp Stamford, Connecticut	–	-US$ 1,12 mi	-53.517	Encerrada
325	325 Congress Asset Management Boston, Massachusetts	–	-US$ 941 mil	-44.908	Encerrada

Ultragenyx Pharmaceutical RARE Valor de mercado US$ 1,65 bi

Ultragenyx Pharmaceutical

RARE

Valor de mercado US$ 1,65 bi